ACADIA PHARMACEUTICALS INC
Biopharmaceutical company developing medicines for CNS disorders and rare diseases.
ACAD | US
Overview
Corporate Details
- ISIN(s):
- US0042251084
- LEI:
- Country:
- United States of America
- Address:
- 12830 EL CAMINO REAL, 92130 SAN DIEGO
- Website:
- https://acadia.com/
- Sector:
- Manufacturing
Description
ACADIA PHARMACEUTICALS INC. is a biopharmaceutical company focused on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases. The company's commercial portfolio includes FDA-approved treatments for Parkinson's disease psychosis and Rett syndrome. Acadia is advancing a diverse clinical pipeline with mid- to late-stage programs targeting conditions such as Alzheimer's disease psychosis and Lewy body dementia psychosis, alongside early-stage programs addressing other unmet patient needs. The company's mission is to provide innovative therapies and support to underserved patient communities.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all ACADIA PHARMACEUTICALS INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ACADIA PHARMACEUTICALS INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ACADIA PHARMACEUTICALS INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
